Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001104659-21-056634
Filing Date
2021-04-28
Accepted
2021-04-28 18:03:47
Documents
7
Period of Report
2021-06-11

Document Format Files

Seq Description Document Type Size
1 DEF 14A tm2114396d2_def14a.htm DEF 14A 428039
2 GRAPHIC tm2114396d2_def14asp1img001.jpg GRAPHIC 5252
3 GRAPHIC tm2114396d2_def14asp1img002.jpg GRAPHIC 2032
4 GRAPHIC image_007.jpg GRAPHIC 15249
5 GRAPHIC tm2114396d2_def14asp4img001.jpg GRAPHIC 1229
6 GRAPHIC tm2114396d2_def14asp1img4.jpg GRAPHIC 252530
7 GRAPHIC tm2114396d2_def14asp1img5.jpg GRAPHIC 190554
  Complete submission text file 0001104659-21-056634.txt   1073124
Mailing Address 5 GREAT VALLEY PARKWAY SUITE 160 MALVERN PA 19355
Business Address 5 GREAT VALLEY PARKWAY SUITE 160 MALVERN PA 19355 484-328-4698
Ocugen, Inc. (Filer) CIK: 0001372299 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36751 | Film No.: 21866170
SIC: 2836 Biological Products, (No Diagnostic Substances)